ื‘ืจื™ืื•ืช ื˜ื•ื‘ื” ื ื•ื‘ืขืช ืžืชื–ื•ื ื” ื ื›ื•ื ื”, ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืกื“ื™ืจื”, ืฉื ืช ืœื™ืœื” ื˜ื•ื‘ื” ื•ืžืฆื™ืืช ืื™ื–ื•ืŸ ืžืชืžืฉืš ื‘ื™ืŸ ื—ื•ื‘ื•ืช ื”ืขื‘ื•ื“ื” ื•ื‘ื™ืช ื”ืกืคืจ ืœื‘ื™ืŸ ื”ืกื™ืคื•ืง ื•ื”ื”ื ืื•ืช ื”ื ื•ื‘ืขื•ืช ืžืžืขืจื›ื•ืช ื™ื—ืกื™ื ื‘ืจื™ืื•ืช, ื‘ื™ืฆื•ืข ืขื‘ื•ื“ื•ืช ืžืชื’ืžืœื•ืช ื•ืขื™ืกื•ืงื™ื ื™ื•ืžื™ื™ื ืื—ืจื™ื ืฉื”ื•ืคื›ื™ื ืืช ื”ื—ื™ื™ื ืœื‘ืขืœื™ ืžืฉืžืขื•ืช, ืžื’ืจื™ื ื•ืžืขื ื™ื™ื ื™ื. ื—ื•ื“ืฉื™ ื”ื—ื•ืจืฃ ื”ื ืชืงื•ืคื” ืžืืชื’ืจืช ืžืื•ื“ ืขื‘ื•ืจ ืื ืฉื™ื ืฉื ืื‘ืงื™ื ื‘ื‘ืขื™ื™ืช ืฉื™ืžื•ืฉ ื‘ืกืžื™ื ืื• ื‘ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ.  

ืคื•ืกื˜ ื–ื” ืžืฆื™ื’ ืกืงื™ืจื” ืชืžืฆื™ืชื™ืช ืฉืœ ืžืžืฆืื™ ื”ืžื—ืงืจ ื”ืžื“ืขื™ ื‘ื ื•ื’ืข ืœื™ืชืจื•ื ื•ืช ืฉื™ืฉ ืœืชื–ื•ื ื” ื˜ื•ื‘ื”, ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืงื‘ื•ืขื” ื•ืฉื™ื ื” ืจื’ื•ืขื” ืขืœ ื”ื‘ืจื™ืื•ืช ื”ื ืคืฉื™ืช. ืืกืงื•ืจ ื’ื ืืช ื”ืžืžืฆืื™ื ืขืœ S-ืื“ื ื•ื–ื™ืœ ืžืชื™ื•ื ื™ืŸ (SAMe) ื•ื“ึถื”ึดื™ื“ึฐืจื•ึน-ืึถืคึดึผื™ืึทื ึฐื“ืจื•ึนืกึฐื˜ึถืจื•ึนืŸ (DHEA), 2 ืชื•ืกืคื™ื ื˜ื‘ืขื™ื™ื ืขื ืชื›ื•ื ื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ.   

ืชื–ื•ื ื” ื ื›ื•ื ื” - ืžืจื›ื™ื‘ ื—ื™ื•ื ื™ ืœื‘ืจื™ืื•ืช ื ืคืฉื™ืช ื˜ื•ื‘ื”

ืžื—ืงืจื™ื ืฉื ืขืจื›ื• ื‘ื ื•ืฉื ืžืฆืื• ื›ื™ ืชื–ื•ื ื” ื˜ื•ื‘ื” ืžืฉืคืจืช ืืช ื”ืจื•ื•ื—ื” ื”ื ืคืฉื™ืช ื•ื”ืจื’ืฉื™ืช. ื—ื•ืกืจื™ื ื‘ืžืกืคืจ ื•ื™ื˜ืžื™ื ื™ื ืžืงื‘ื•ืฆื” B, ื›ื’ื•ืŸ ื—ื•ืžืฆื” ืคื•ืœื™ืช ื•-B-12, ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืžืกื•ื’ ืื•ืžื’ื”-3, ื•ื™ื˜ืžื™ืŸ D, ืื‘ืฅ, ื•ืžื’ื ื–ื™ื•ื ืงืฉื•ืจื™ื ืœืกื™ื›ื•ืŸ ืžื•ื’ื‘ืจ ืœืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ. ืžื–ื•ื ื•ืช ืขืฉื™ืจื™ื ื‘ื•ื•ื™ื˜ืžื™ื ื™ื ืžืงื‘ื•ืฆื” B, ื›ื’ื•ืŸ ื“ื’ื ื™ื ืžืœืื™ื ื•ื™ืจืงื•ืช ื‘ืขืœื™ ืขืœื™ื ื™ืจื•ืงื™ื ื›ื”ื™ื, ืขืฉื•ื™ื™ื ืœื”ื™ื•ืช ื™ืขื™ืœื™ื ื‘ืžื™ื•ื—ื“ ื›ื ื’ื“ ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ. ื•ื™ื˜ืžื™ื ื™ื ืžืกื•ื™ืžื™ื ืžืงื‘ื•ืฆื” B ืžืชืคืงื“ื™ื ื›ืงื•ืคืงื˜ื•ืจื™ื ืฉืœ ืื ื–ื™ื ืฉืžืกื™ื™ืข ืœืกื™ื ืชื–ื” ืฉืœ ืžื•ืœื™ื›ื™ื ืขืฆื‘ื™ื™ื ื›ื’ื•ืŸ ืกืจื•ื˜ื•ื ื™ืŸ, ื“ื•ืคืžื™ืŸ ื•ื ื•ืจืื“ืจื ืœื™ืŸ ื”ืžืขื•ืจื‘ื™ื ื‘ื•ื•ื™ืกื•ืช ืžืฆื‘ื™ ืจื•ื—. ื—ื•ืžืจื™ื ื˜ื‘ืขื™ื™ื ืื—ืจื™ื ื›ื’ื•ืŸ ืื‘ืฅ, ืžื’ื ื–ื™ื•ื ื•ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืžืกื•ื’ ืื•ืžื’ื” 3 ืžืขื•ื“ื“ื™ื ืกื™ื ืชื–ื” ืžื•ื’ื‘ืจืช ืฉืœ ื’ื•ืจื ื ื•ื™ืจื•ื˜ืจื•ืคื™ ืžื•ื—ื™ (BDNF), ื”ืžืฉืคืจ ืืช ื”ื ื•ื™ืจื•ืคืœืกื˜ื™ื•ืช (ื’ืžื™ืฉื•ืช ืžื•ื—ื™ืช), ื•ื›ืชื•ืฆืื” ืžื›ืš ื”ืžื•ื— ื”ื•ืคืš ืœื—ืกื™ืŸ ื™ื•ืชืจ ืœืœื—ืฆื™ื ื•ื”ืกื™ื›ื•ืŸ ืœืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ ืคื•ื—ืช. 

ืœ

ื—ื•ืžืฆื•ืช ืื•ืžื’ื” 3 ื•ืœืžืกืคืจ ื•ื™ื˜ืžื™ื ื™ื ืžืงื‘ื•ืฆื” B  ื™ืฉ ืชืคืงื•ื“ื™ื ืื ื˜ื™ ื“ืœืงืชื™ื™ื ื•ื ื•ื™ืจื• ื”ื’ื ืชื™ื™ื (neuroprotective) ืžื•ืขื™ืœื™ื, ืฉืขืฉื•ื™ื™ื ืœื”ืขืฆื™ื ืืช ื”ืฉืคืขืชื ื”ื—ื™ื•ื‘ื™ืช ืขืœ ืžืฆื‘ื™ ื”ืจื•ื—. ื‘ืกืงื™ืจื” ืฉื™ื˜ืชื™ืช ืฉื ืขืจื›ื” ืœืื—ืจื•ื ื” ื ืžืฆืื• 12 ื—ื•ืžืจื™ื ืžื–ื™ื ื™ื ื—ื™ื•ื ื™ื™ื ืฉื™ืขื™ืœื™ื ื ื’ื“ ื“ื™ื›ืื•ืŸ: ื—ื•ืžืฆื” ืคื•ืœื™ืช, ื‘ืจื–ืœ, ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืžืกื•ื’ ืื•ืžื’ื” 3 ืืจื•ื›ื•ืช ืฉืจืฉืจืชEPA, DHA),ืžื’ื ื–ื™ื•ื,, ืืฉืœื’ืŸ, ืกืœื ื™ื•ื, ืชื™ืืžื™ืŸ, ื•ื™ื˜ืžื™ืŸ A, ื•ื™ื˜ืžื™ืŸ B6,  ื•ื™ื˜ืžื™ืŸ B12, ื•ื™ื˜ืžื™ืŸ C, ื•ืื‘ืฅ. ืžื—ื‘ืจื™ ื”ืžืืžืจ ืื™ืชืจื• ื‘ื‘ืกื™ืก ื”ื ืชื•ื ื™ื ืฉืœ ื”-FDA ืžืกืคืจ ืžื–ื•ื ื•ืช ืฉืžื›ื™ืœื™ื ืืช ื”ื›ืžื•ื™ื•ืช ื”ื’ื‘ื•ื”ื•ืช ื‘ื™ื•ืชืจ ืฉืœ ืœืคื—ื•ืช ืื—ื“ ืžื”ื—ื•ืžืจื™ื ื”ืžื–ื™ื ื™ื ืืœื”. ืžื–ื•ื ื•ืช ืขื ื”ื™ืขื™ืœื•ืช ื”ื’ื‘ื•ื”ื” ื‘ื™ื•ืชืจ ื ื’ื“ ื“ื™ื›ืื•ืŸ ื›ืœืœื• ืฆื“ืคื•ืช ื•ืžื•ืœื™ื, ืคื™ืจื•ืช ื™ื ื ื•ืกืคื™ื, ื‘ืฉืจื™ื ืื•ืจื’ื ื™ื™ื, ื™ืจืงื•ืช ืขืœื™ื™ื, ื—ืกื”, ืคืœืคืœื™ื, ื•ื™ืจืงื•ืช ืžืฆืœื™ื‘ื™ื ื›ืžื• ื‘ืจื•ืงื•ืœื™, ื›ืจื•ื‘ื™ืช, ื›ืจื•ื‘ ื•ื›ืจื•ื‘ ื ื™ืฆื ื™ื. 

ืžืžืฆืื™ ืžื—ืงืจื™ื ืืคื™ื“ืžื™ื•ืœื•ื’ื™ื™ื ืชื•ืžื›ื™ื ื‘ื›ืš ืฉืื ืฉื™ื ื”ืฆื•ืจื›ื™ื ืžื–ื•ืŸ ืžืœื - ื‘ื ื™ื’ื•ื“ ืœืžื–ื•ืŸ ืžืขื•ื‘ื“ ื•ื“ื™ืื˜ื•ืช ืžื–ื•ืŸ ืžื”ื™ืจ - ื”ืคื—ื™ืชื• ืืช ื”ืกื™ื›ื•ืŸ ืœืคืชื— ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ. ืœื“ื•ื’ืžื”, ื‘ืงืจื‘ ืื ืฉื™ื ืฉื”ืชืคืจื™ื˜ ืฉืœื”ื ืžื‘ื•ืกืก ืขืœ ืชื–ื•ื ื” ื™ื ืชื™ื›ื•ื ื™ืช  ืื• ืขืœ ื”ืชื–ื•ื ื” ื”ืžืกื•ืจืชื™ืช ืฉืœ ื ื•ืจื‘ื’ื™ื”, ื™ืคืŸ ื•ืกื™ืŸ, ื”ืขืฉื™ืจื” ื‘ื™ืจืงื•ืช ื•ื‘ื“ื’ื™ื, ื”ืกื™ื›ื•ืŸ ืœืกื‘ื•ืœ ืžืžืฆื‘ื™ ืจื•ื— ื“ื›ืื•ื ื™ื™ื ื ืžื•ืš ื‘-30% ื‘ื”ืฉื•ื•ืื” ืœืื ืฉื™ื ืขื ื”ื“ื‘ืงื•ืช ื”ื ืžื•ื›ื” ื‘ื™ื•ืชืจ ื‘ืชื–ื•ื ื” ื™ื ืชื™ื›ื•ื ื™ืช. ื‘ืขื•ื“ ืฉื”ืชื–ื•ื ื” ื”ื™ื ืชื™ื›ื•ื ื™ืช ื•ื“ื™ืื˜ื•ืช ืžืกื•ืจืชื™ื•ืช ืื—ืจื•ืช ืขืฉื™ืจื•ืช ื™ื•ืชืจ ื‘ืžื–ื•ื ื•ืช ืฉืฆื•ื™ื ื•, ื”ืชื–ื•ื ื” ื”ืืžืจื™ืงืื™ืช ื”ืžืžื•ืฆืขืช ืžื›ื™ืœื” ืคื—ื•ืช ืžื–ื•ื ื•ืช ื‘ืขืœื™ ืขืจืš ืชื–ื•ื ืชื™ ื’ื‘ื•ื” ืฉื™ื›ื•ืœื™ื ืœื”ื•ืขื™ืœ ื ื’ื“ ื“ื™ื›ืื•ืŸ. ืœืจืžื•ืช ื”ืฆืจื™ื›ื” ืฉืœ ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ื‘ืชืคืจื™ื˜ ื”ืชื–ื•ื ื” ืขืฉื•ื™ ืœื”ื™ื•ืช ืงืฉืจ ื™ืฉื™ืจ ืœืจืžื•ืช ืฉื•ื ื•ืช ืฉืœ ื“ื™ื›ืื•ืŸ, ื›ืš ืขื•ืœื” ืžื”ืฉื•ื•ืื” ื‘ื™ืŸ ืžื“ื™ื ื•ืช ืžืชื•ืขืฉื•ืช ืœืชืจื‘ื•ื™ื•ืช ืžืกื•ืจืชื™ื•ืช ื™ื•ืชืจ. ืžื—ืงืจื™ื ืืคื™ื“ืžื™ื•ืœื•ื’ื™ื™ื ืžืจืื™ื ืฉื™ืฉ ืœื›ืื•ืจื” ืงืฉืจ ื”ืคื•ืš ื‘ื™ืŸ ื”ืกื™ื›ื•ืŸ ืœืกื‘ื•ืœ ืžื“ื™ื›ืื•ืŸ ืœื‘ื™ืŸ ืฆืจื™ื›ืช ืฉืžืŸ ื“ื’ื™ื. ืžื“ื™ื ื•ืช ืฉื‘ื”ืŸ ื“ื’ื™ื ืžื”ื•ื•ื™ื ื—ืœืง ื—ืฉื•ื‘ ืžื”ืชื–ื•ื ื” ื”ืžืžื•ืฆืขืช ืžืื•ืคื™ื™ื ื•ืช ื‘ืฉื™ืขื•ืจื™ื ื ืžื•ื›ื™ื ืžืฉืžืขื•ืชื™ืช ืฉืœ ืžืฆื‘ ืจื•ื— ื“ื™ื›ืื•ื ื™ ื•ืื•ื‘ื“ื ื•ืช. ืœื“ื•ื’ืžื”, ื‘ื™ืคืŸ, ืฉื‘ื” ืฆืจื™ื›ืช ื”ื“ื’ื™ื ื’ื‘ื•ื”ื” ืžืื•ื“, ืจืง 0.12% ืžื”ืื•ื›ืœื•ืกื™ื™ื” ื—ื•ื•ื™ื ืžืฆื‘ ืจื•ื— ื“ื™ื›ืื•ื ื™ ื‘ืฉื ื” ื ืชื•ื ื”. ื”ื ื™ื• ื–ื™ืœื ื“ื™ื, ืœืขื•ืžืช ื–ืืช, ืฆื•ืจื›ื™ื ื™ื—ืกื™ืช ืžืขื˜ ื“ื’ื™ื, ื•ืฉื ื›-6% ื—ื•ื•ื™ื ื“ื™ื›ืื•ืŸ ื‘ืฉื ื” ื ืชื•ื ื”. 

ื‘ื ื•ืกืฃ ืœื›ืš ืฉืœืชื•ืกืคื™ ืžื–ื•ืŸ ืžืกื•ื™ืžื™ื ื™ืฉ ื”ืฉืคืขื” ืœื˜ื•ื‘ื” ืขืœ ื‘ืจื™ืื•ืช ื”ื ืคืฉ, ืงื™ื™ืžื•ืช ืขื“ื•ื™ื•ืช ืœื›ืš ืฉื”ืžื™ืงืจื•ื‘ื™ื•ื - ื”ืžื•ืจื›ื‘ ืžืžื™ืงืจื•ืื•ืจื’ื ื™ื–ืžื™ื ื”ืžืื›ืœืกื™ื ืืช ื”ืžืขื™ ื”ื’ืก ื•ื”ื“ืง - ืชื•ืจื ืœื‘ืจื™ืื•ืช ื”ื’ื•ืคื ื™ืช ื•ื”ื ืคืฉื™ืช ื”ื›ืœืœื™ืช ื‘ืืžืฆืขื•ืช ืžื’ื•ื•ืŸ ืžื ื’ื ื•ื ื™ื, ืฉื—ืœืงื ืขืฉื•ื™ื™ื ืœื”ืฉืคื™ืข ืขืœ ืžื•ืœื™ื›ื™ื ืขืฆื‘ื™ื™ื ื•ืขืœ ืžื•ืœืงื•ืœื•ืช ื“ืœืงืชื™ื•ืช ื”ืžืขื•ืจื‘ื•ืช ื‘ื•ื•ื™ืกื•ืช ืžืฆื‘ ื”ืจื•ื—. 

ืฉื™ื ื” ืจื’ื•ืขื” ื—ืฉื•ื‘ื” ืœื‘ืจื™ืื•ืช ื ืคืฉื™ืช ื˜ื•ื‘ื”

ืฉื™ื ื” ืฉืžื•ืคืจืขืช ื‘ืื•ืคืŸ ื›ืจื•ื ื™ ืขืœื•ืœื” ืœื’ืจื•ื ืœื”ืฉืœื›ื•ืช ืฉืœื™ืœื™ื•ืช ืžืฉืžืขื•ืชื™ื•ืช ืขืœ ืžืฆื‘ ื”ืจื•ื— ื•ื”ืชืคืงื•ื“ ื”ืงื•ื’ื ื™ื˜ื™ื‘ื™. ื’ื™ืฉื•ืช ื’ื•ืฃ-ื ืคืฉ ืฉื™ื“ื•ืขื•ืช ื›ืžื•ืขื™ืœื•ืช ืœื ื“ื•ื“ื™ ืฉื™ื ื” ื›ื•ืœืœื•ืช ื”ืจืคื™ื™ืช ืฉืจื™ืจื™ื ื”ื“ืจื’ืชื™ืช, ืžื“ื™ื˜ืฆื™ื”, ื“ืžื™ื•ืŸ ืžื•ื“ืจืš ื•ื”ื™ืคื ื•ื–ื”. ื”ืจืคื™ื™ืช ืฉืจื™ืจื™ื ื”ื“ืจื’ืชื™ืช ื•ื ืฉื™ืžื” ืขืžื•ืงื” ืžืžื•ืฉื›ืช ื™ืขื™ืœื•ืช ื‘ืžื™ื•ื—ื“ ืœื”ื™ืจื“ืžื•ืช ืžื”ื™ืจื” ื™ื•ืชืจ ืืฆืœ ืื ืฉื™ื ืฉืกื•ื‘ืœื™ื ืžื ื“ื•ื“ื™ ืฉื™ื ื” ื›ืจื•ื ื™ื™ื. ื˜ื›ื ื™ืงื•ืช ืฉืžืกื™ื™ืขื•ืช ืœื”ืฉื’ืช ืจื’ื™ืขื” ืขืžื•ืงื” ืžื’ื‘ื™ืจื•ืช ืืช ื”ืคืขื™ืœื•ืช ื”ืคืืจื-ืกื™ืžืคืชื˜ื™ืช (ื›ืœื•ืžืจ, ื”ื—ืœืง ืฉืœ ืžืขืจื›ืช ื”ืขืฆื‘ื™ื ื”ืื•ื˜ื•ื ื•ืžื™ืช ืฉืžืื˜ ืืช ื”ืœื‘ ื•ืžืจื’ื™ืข ืืช ื”ื ืคืฉ), ื•ืžืคื—ื™ืชื•ืช ืืช ื”ืคืขื™ืœื•ืช ื”ืกื™ืžืคืชื˜ื™ืช (ื›ืœื•ืžืจ, ื”ื—ืœืง ืฉืœ ืžืขืจื›ืช ื”ืขืฆื‘ื™ื ื”ืื•ื˜ื•ื ื•ืžื™ืช ื”ืžื’ื‘ื™ืจ ืืช ืงืฆื‘ ื”ืœื‘ ื•ื’ื•ืจื ืœืขืจื•ืช ื’ื‘ื•ื”ื” ื™ื•ืชืจ). ืื ืฉื™ื ืฉืžืชืงืฉื™ื ืœื”ื™ืจื“ื ื‘ื’ืœืœ ื—ืจื“ื” ืื• ืœื—ืฅ ื‘ืขื‘ื•ื“ื” ื™ื›ื•ืœื™ื ืœื ืกื•ืช ืœื”ืื–ื™ืŸ ืœื“ืžื™ื•ืŸ ืžื•ื“ืจืš ืžืจื’ื™ืข ื›ืฉื‘ืจืงืข ื ืฉืžืขื™ื ืฆืœื™ืœื™ื ื•ืงื•ืœื•ืช ืžื”ื˜ื‘ืข, ื•ืœื”ืชื—ื™ืœ ื‘ื›ืš 30 ื“ืงื•ืช ืœืคื ื™ ืฉืขืช ื”ืฉื™ื ื” ื”ืจื’ื™ืœื” ืฉืœื”ื. ืื ืฉื™ื ื”ืกื•ื‘ืœื™ื ืžื‘ืขื™ื•ืช ืฉื™ื ื” ื”ืงืฉื•ืจื•ืช ืœื›ืื‘ื™ื ื›ืจื•ื ื™ื™ื ืื• ืœื‘ืขื™ื” ืจืคื•ืื™ืช ืื—ืจืช ืžื’ื™ื‘ื™ื ื‘ื“ืจืš ื›ืœืœ ืœืฉื™ืžื•ืฉ ื‘ื˜ื›ื ื™ืงืช ื”ืจืคื™ื™ืช ืฉืจื™ืจื™ื ื”ื“ืจื’ืชื™ืช, ื•ืืœื” ืฉืœื ืžืฆืœื™ื—ื™ื ืœื”ื™ืจื“ื ื‘ื’ืœืœ ื“ืื’ื” ื›ืจื•ื ื™ืช ื ื•ื˜ื™ื ื™ื•ืชืจ ืœื”ื’ื™ืข ืœืฉื™ื ื” ืจื’ื•ืขื” ื‘ืขื–ืจืช ื“ืžื™ื•ืŸ ืžื•ื“ืจืš. 

ื›ืืฉืจ ืžื“ื•ื‘ืจ ื‘ื ื“ื•ื“ื™ ืฉื™ื ื” ืงืœื™ื ืื• ื”ืชืขื•ืจืจื•ื™ื•ืช ืชื“ื™ืจื•ืช ื‘ื”ืชื—ืœืช ื”ืฉื™ื ื” (situational insomnia) ื’ื™ืฉื•ืช ื”ืจืคื™ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ื•ืช ื›ื’ื•ืŸ ืžื“ื™ื˜ืฆื™ื” ื•ื“ืžื™ื•ืŸ ืžื•ื“ืจืš ื”ืŸ ื›ื›ืœ ื”ื ืจืื” ื™ืขื™ืœื•ืช ื™ื•ืชืจ ืžืืฉืจ ื”ืจืคื™ื™ืช ืฉืจื™ืจื™ื ื”ื“ืจื’ืชื™ืช, ืืš ืžื•ืขื™ืœื•ืช ืคื—ื•ืช ื‘ืžืฆื‘ื™ื ืฉืœ ื ื“ื•ื“ื™ ืฉื™ื ื” ื—ืžื•ืจื™ื. (National Institute of Health Technology Assessment Panel, 1996). ืื ืฉื™ื ื”ืกื•ื‘ืœื™ื ืžื”ืคืจืขื•ืช ื›ืื‘ ื›ืจื•ื ื™ื•ืช ื›ืžื• ืคื™ื‘ืจื•ืžื™ืืœื’ื™ื” ืื• ื“ืœืงืช ืคืจืงื™ื ืžื“ื•ื•ื—ื™ื ืฉืขื™ืกื•ื™ ืงื‘ื•ืข ืžืืจื™ืš ืžืฉืžืขื•ืชื™ืช ืืช ืžืฉืš ื”ืฉื™ื ื” ืฉืœื”ื ื•ืžืคื—ื™ืช ื›ืื‘ื™ื. ืื ืฉื™ื ื”ืกื•ื‘ืœื™ื ืžื ื“ื•ื“ื™ ืฉื™ื ื” ื›ืจื•ื ื™ื™ื ืฉืžืชืจื’ืœื™ื ื‘ืื•ืคืŸ ืงื‘ื•ืข ื˜ื›ื ื™ืงื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช-ื”ืชื ื”ื’ื•ืชื™ืช, ืขื ืื• ื‘ืœื™ ื ื˜ื™ืœืช ื‘ื ื–ื•ื“ื™ืื–ืคื™ืŸ ืื• ืชืจื•ืคืช ืžืจื’ื™ืขื•ืช-ื”ื™ืคื ื•ื˜ื™ื•ืช ืื—ืจื•ืช, ืžื“ื•ื•ื—ื™ื ื›ื™ ื’ื™ืฉื•ืช ืœื-ืคืจืžืงื•ืœื•ื’ื™ื•ืช ืื• ืžืฉื•ืœื‘ื•ืช ื™ืขื™ืœื•ืช ื™ื•ืชืจ ืžืืฉืจ ืชืจื•ืคื•ืช ื‘ืœื‘ื“. ื™ืชืจื” ืžื›ืš, ื‘ื”ืฉื•ื•ืื” ืœื˜ื™ืคื•ืœ ืชืจื•ืคืชื™ ื‘ืœื‘ื“, ื’ื™ืฉื•ืช ืœื ืคืจืžืงื•ืœื•ื’ื™ื•ืช ืื• ืื™ื ื˜ื’ืจื˜ื™ื‘ื™ื•ืช ืžืกื™ื™ืขื•ืช ืœืฉื™ื ื” ืžืฉื•ืคืจืช ืžืžื•ืฉื›ืช ื™ื•ืชืจ. ืžื˜ื”-ืื ืœื™ื–ื” ืฉืœ 66 ืžื—ืงืจื™ื (ืขื ื›-2000 ืžื˜ื•ืคืœื™ื ื‘ืžืฆื˜ื‘ืจ) ืฉื‘ื—ื ื” ื˜ื™ืคื•ืœ ื‘ื ื“ื•ื“ื™ ืฉื™ื ื” ื‘ืขื–ืจืช ื’ื™ืฉื•ืช ื”ืจืคื™ื” ื•ื’ื™ืฉื•ืช ื’ื•ืฃ-ื ืคืฉ ื”ืขืœืชื” ื›ื™ ื‘ื›ืœ ื”ืฉื™ื˜ื•ืช ืฉื ื‘ื“ืงื• ื ืฆืคื• "ื™ืชืจื•ื ื•ืช ืืžื™ื ื™ื ื•ืœืื•ืจืš ื–ืžืŸ" ืฉื”ื™ื• ืขื“ื™ืคื™ื ืขืœ ืฉื™ืžื•ืฉ ื‘ืคืœืฆื‘ื•, ื•ืกื™ื™ืขื• ืœืฉืคืจ ืืช ืื™ื›ื•ืช ื”ืฉื™ื ื” ื•ืœืงืฆืจ ืืช ืžืฉืš ื”ื–ืžืŸ ืฉื ื“ืจืฉ ื›ื“ื™ ืœื”ื™ืจื“ื. ืžื˜ื”-ืื ืœื™ื–ื” ื ืคืจื“ืช ื”ืขืœืชื” ืฉืœืžืจื•ืช ืฉื˜ื™ืคื•ืœื™ื ืœื ืคืจืžืงื•ืœื•ื’ื™ื™ื ื‘ื ื“ื•ื“ื™ ืฉื™ื ื” ื›ืจื•ื ื™ื™ื ื”ื ื™ืงืจื™ื ื™ื•ืชืจ ื‘ื”ืชื—ืœื” ื•ื“ื•ืจืฉื™ื ื–ืžืŸ ืจื‘ ื™ื•ืชืจ ื›ื“ื™ ืœื”ืฉืคื™ืข, ื‘ื”ืฉื•ื•ืื” ืœื˜ื™ืคื•ืœ ืชืจื•ืคืชื™ ืงื•ื ื‘ื ืฆื™ื•ื ืืœื™, ื”ืจื™ ืฉื‘ื˜ื•ื•ื— ื”ืจื—ื•ืง ื”ื ืืžื™ื ื™ื, ืžื‘ื™ืื™ื ืœืชื•ืขืœืช ืžืชืžืฉื›ืช ื•ื—ืกื›ื•ื ื™ื™ื ื™ื•ืชืจ ืžืืฉืจ ืชืจื•ืคื•ืช ื‘ืœื‘ื“.

ืื ืฉื™ื ืจื‘ื™ื ืฉืกื•ื‘ืœื™ื ืžื ื“ื•ื“ื™ ืฉื™ื ื” ื›ืจื•ื ื™ื™ื ืžืคืชื—ื™ื ืชืœื•ืช ื‘ื‘ื ื–ื•ื“ื™ืื–ืคื™ื ื™ื ื›ืžื• ืœื•ืจืื–ืคืื (Ativanโ„ข), ื“ื™ืื–ืคืื (Valiumโ„ข) ื•ืงืœื•ื ื–ืืคืื (Klonopinโ„ข). ื ื˜ื™ืœืช ืžืœื˜ื•ื ื™ืŸ  ืขืฉื•ื™ื” ืœื”ืงืœ ืขืœ ื”ืคืกืงืช ื”ืฉื™ืžื•ืฉ ื‘ื‘ื ื–ื•ื“ื™ืื–ืคื™ื ื™ื ืœืื—ืจ ืฉื™ืžื•ืฉ ื›ืจื•ื ื™, ืื•ืœื ื”ืžืžืฆืื™ื ืื™ื ื ืขืงื‘ื™ื™ื. ื‘ืžื—ืงืจ ื—ื“ ืกืžื™ื•ืช, ืžื‘ื•ืงืจ ืคืœืฆื‘ื•, ืฉื ืžืฉืš 12 ืฉื‘ื•ืขื•ืช ื ืžืฆื ื›ื™ ืœืื ืฉื™ื ืฉืงื™ื‘ืœื• 2 ืž"ื’ ืžืœื˜ื•ื ื™ืŸ ื‘ืฉื—ืจื•ืจ ืžื‘ื•ืงืจ ื”ื™ื” ืกื™ื›ื•ื™ ื’ื‘ื•ื” ื™ื•ืชืจ ืœื”ืคืกื™ืง ืืช ื”ืฉื™ืžื•ืฉ ื‘ื‘ื ื–ื•ื“ื™ืื–ืคื™ื ื™ื ื‘ื”ืฉื•ื•ืื” ืœืืœื• ืฉืงื™ื‘ืœื• ืคืœืฆื‘ื•. ืื ืฉื™ื ืฉื ื˜ืœื• ืžืœื˜ื•ื ื™ืŸ ื“ื™ื•ื•ื—ื• ืขืœ ืฉื™ืคื•ืจ ืžืฉืžืขื•ืชื™ ืžืื•ื“ ื‘ืื™ื›ื•ืช ื”ืฉื™ื ื” ืฉืœื”ื ื‘ื”ืฉื•ื•ืื” ืœืงื‘ื•ืฆืช ื”ืคืœืฆื‘ื•, ื•ืžืจื‘ื™ืช ื”ื ื‘ื“ืงื™ื ืฉื”ืžืฉื™ื›ื• ืœื™ื˜ื•ืœ ืžืœื˜ื•ื ื™ืŸ ื‘ืฉื—ืจื•ืจ ืžื‘ื•ืงืจ ืœื ื ื˜ืœื• ื‘ื ื–ื•ื“ื™ืื–ืคื™ื ื™ื ื‘ืžืฉืš ืฉื™ืฉื” ื—ื•ื“ืฉื™ื ืœืื—ืจ ืชื•ื ื”ืžื—ืงืจ. ื‘ื ื™ื’ื•ื“ ืœืžืžืฆืื™ื ื”ื—ื™ื•ื‘ื™ื™ื ืฉืœืขื™ืœ, ื‘ืกืงื™ืจื” ืฉื™ื˜ืชื™ืช ื•ืžื˜ื-ืื ืœื™ื–ื” ืขื“ื›ื ื™ื•ืช ื™ื•ืชืจ ืœื ื ืžืฆืื” ืฉื•ื ืขื“ื•ืช ืœื›ืš ืฉื ื˜ื™ืœืช ืžืœื˜ื•ื ื™ืŸ ืžืงืœื” ืขืœ ื”ืคืกืงืช ื”ืฉื™ืžื•ืฉ ื‘ื‘ื ื–ื•ื“ื™ืื–ืคื™ืŸ, ื•ืฉื”ื”ืฉืคืขื” ืฉืœ ื ื˜ื™ืœืช ืžืœื˜ื•ื ื™ืŸ ืขืœ ืื™ื›ื•ืช ื”ืฉื™ื ื” ืื™ื ื” ืขืงื‘ื™ืช. 

ื”ื™ืชืจื•ื ื•ืช ืฉืœ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืงื‘ื•ืขื” ื›ื ื•ื’ื“ืช ื“ื™ื›ืื•ืŸ 

ื—ื•ื“ืฉื™ ื”ืกืชื™ื• ื•ื”ื—ื•ืจืฃ ื”ื ืžืืชื’ืจื™ื ื‘ืžื™ื•ืขื“ ืขื‘ื•ืจ ืื ืฉื™ื ืจื‘ื™ื ืฉื ืื‘ืงื™ื ื‘ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ. ืœืžืจื•ืช ืฉื˜ื™ืคื•ืœื™ื ื ืคื•ืฆื™ื ืžืงื•ื‘ืœื™ื ื›ื’ื•ืŸ ืชืจื•ืคื•ืช ื•ืคืกื™ื›ื•ืชืจืคื™ื” ืžื•ืขื™ืœื™ื ื‘ื“ืจืš ื›ืœืœ, ื”ืจื™ ืฉื‘ืžืงืจื™ื ืจื‘ื™ื ื’ื™ืฉื•ืช ืงื•ื ื‘ื ืฆื™ื•ื ืืœื™ื•ืช ืงื™ื™ืžื•ืช ืื™ื ืŸ ืžืฆืœื™ื—ื•ืช ืœื”ืงืœ ืขืœ ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ. ืœื”ืœืŸ ืกื™ื›ื•ื ืชืžืฆื™ืชื™ ืฉืœื™ ืฉืœ ืขื™ืงืจื™ ื”ืžื—ืงืจื™ื ื”ืชื•ืžื›ื™ื ื‘ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืกื“ื™ืจื” ื•ื ื˜ื™ืœืช ืชื•ืกืคื™ ืชื–ื•ื ื” ื˜ื‘ืขื™ื™ื ื›ืžื•ืขื™ืœื™ื ืœืฉื™ืคื•ืจ ืžืฆื‘ ื”ืจื•ื—. 

ืžืžืฆืื™ื ืฉืœ ื ื™ืกื•ื™ื™ื ืžื‘ื•ืงืจื™ื ื•ื‘ื™ืงื•ืจื•ืช ืฉื™ื˜ืชื™ื•ืช ืงื•ื‘ืขื™ื ื›ื™ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืงื‘ื•ืขื” ืžืฉืคืจืช ืžืฆื‘ื™ ืจื•ื— ื“ื™ื›ืื•ื ื™ื™ื. ืœืื ืฉื™ื ืคืขื™ืœื™ื ื™ื•ืชืจ ื™ืฉ ืกื™ื›ื•ืŸ ืžื•ืคื—ืช ื”ืŸ ืœืžืฆื‘ื™ ืจื•ื— ื“ื™ื›ืื•ื ื™ื™ื ื•ื”ืŸ ืœืžื—ืœื•ืช ืœื‘ ื•ื›ืœื™ ื“ื. ื”ื”ืฉืคืขื•ืช ื”ืžื™ื™ื“ื™ื•ืช ื•ืืจื•ื›ื•ืช ื”ื˜ื•ื•ื— ืฉื™ืฉ ืœืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืขืœ ืžืฆื‘ ื”ืจื•ื— ืžืชื•ื•ื›ื•ืช ืขืœ ื™ื“ื™ ื’ื•ืจืžื™ื ืžืจื•ื‘ื™ื ืฉืžืขืœื™ื ืืช ื”ืจืžื•ืช ืฉืœ ืื ื“ื•ืจืคื™ื ื™ื, ื“ื•ืคืžื™ืŸ, ื ื•ืจืื“ืจื ืœื™ืŸ ื•ืกืจื•ื˜ื•ื ื™ืŸ ื‘ืžื•ื—, ืžืขื•ื“ื“ื™ื ื”ืชืคืชื—ื•ืช ืฉืœ ื ื•ื™ืจื•ื ื™ื ื—ื“ืฉื™ื ื‘ืžื•ื— (ื›ืœื•ืžืจ ื ื•ื™ืจื•ื’ื ื–ื”), ืžืคื—ื™ืชื™ื ืœื—ืฅ ื—ืžืฆื•ื ื™, ื•ืžืฉืคืจื™ื ืืช ื”ืชืคืงื•ื“ ื”ื—ื™ืกื•ื ื™. ืžืžืžืฆืื™ ืžื—ืงืจ ืคื™ื™ืœื•ื˜ ืงื˜ืŸ ืฉืœ fMRI ืขื•ืœื” ื›ื™ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืกื“ื™ืจื” ืขืฉื•ื™ื” ืœืขื•ื“ื“ ืขืœื™ื™ื” ื‘ื’ืžื™ืฉื•ืช ื”ืžื•ื—ื™ืช ืฉืœ ืื–ื•ืจื™ื ืžืกื•ื™ืžื™ื ื‘ืžื•ื— (ื ื•ื™ืจื•-ืคืœืกื˜ื™ื•ืช), ื•ืื•ืœื™ ืืฃ ืœืกื™ื™ืข ืœืฉืคืจ ืืช ืžืฆื‘ ื”ืจื•ื—. 

ืžื˜ื”-ืื ืœื™ื–ื” ืฉืœ ืžื—ืงืจื™ื ืžื‘ื•ืงืจื™ื (977 ื ื‘ื“ืงื™ื ื‘ืกืš ื”ื›ืœ) ืฉื‘ื“ืงื• ื‘ื™ืฆื•ืข ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื‘ืœื‘ื“ ืื• ื‘ืฉื™ืœื•ื‘ ืขื ืชืจื•ืคื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ ื”ืขืœืชื” ื›ื™ ืื™ืžื•ืŸ ืงื‘ื•ืข ืžืฉืคื™ืข ืœื˜ื•ื‘ื” ืขืœ ืžืฆื‘ ืจื•ื— ื“ื™ื›ืื•ื ื™. ืกืงื™ืจื” ืฉื™ื˜ืชื™ืช ืฉืœ ืžื—ืงืจื™ื ืขืœ ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื›ืชืจืคื™ื” ื ื•ืกืคืช ืืฆืœ ืื ืฉื™ื ื”ืžืื•ื‘ื—ื ื™ื ื›ืกื•ื‘ืœื™ื ืžื”ืคืจืขืช ื“ื™ื›ืื•ืŸ ื—ืžื•ืจื” ื”ืขืœืชื” ื›ื™ ืื ืฉื™ื ื‘ื“ื™ื›ืื•ืŸ ื”ืžืชืืžื ื™ื ื‘ืื•ืคืŸ ืงื‘ื•ืข ืžื’ื™ื‘ื™ื ื‘ืื•ืคืŸ ืขืงื‘ื™ ื˜ื•ื‘ ื™ื•ืชืจ ื‘ื”ืฉื•ื•ืื” ืœืื ืฉื™ื ื”ื ื•ื˜ืœื™ื ืชืจื•ืคื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ ืืš ืื™ื ื ืžืชืืžื ื™ื. ืคืขื™ืœื•ืช ืื™ืจื•ื‘ื™ืช ืกื“ื™ืจื” ืขืฉื•ื™ื” ืœืฉืคืจ ืืช ื”ืชืคืงื•ื“ ื”ืงื•ื’ื ื™ื˜ื™ื‘ื™ ื‘ืงืจื‘ ืื ืฉื™ื ืขื ื“ื™ื›ืื•ืŸ ื›ืจื•ื ื™ ืฉืกื•ื‘ืœื™ื ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ืžืงืฉื™ื™ ื—ืฉื™ื‘ื” ื•ื–ื™ื›ืจื•ืŸ. ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ืงื‘ื•ืขื” ื’ื ืžืฉืคืจืช ืืช ืื™ื›ื•ืช ื”ืฉื™ื ื” ืฉืœ ืื ืฉื™ื ืฉืื™ื ื ืžื’ื™ื‘ื™ื ืœื˜ื™ืคื•ืœ ื‘ืชืจื•ืคื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ. ืคืขื™ืœื•ืช ื’ื•ืคื ื™ืช ื›ืžืฉืคืจืช ืืช ืื™ื›ื•ืช ื”ืฉื™ื ื” ืขืฉื•ื™ื” ืœืชืจื•ื ืœื—ื•ืกืŸ ื ืคืฉื™ ื•ืœืชืคืงื•ื“ ื™ื•ืžื™ื•ืžื™ ื’ื‘ื•ื”ื™ื ื™ื•ืชืจ ืืฆืœ ืื ืฉื™ื ืฉืกื•ื‘ืœื™ื ืžื ื“ื•ื“ื™ ืฉื™ื ื” ื›ืชื•ืฆืื” ืžื“ื™ื›ืื•ืŸ ื›ืจื•ื ื™. ื“ืจื•ืฉื™ื ืžื—ืงืจื™ื ื ื•ืกืคื™ื ื›ื“ื™ ืœืงื‘ื•ืข ืืช ืžืฉืš ื”ื–ืžืŸ ื•ื”ืชื“ื™ืจื•ืช ืฉืœ ื”ืคืขื™ืœื•ืช ื”ื’ื•ืคื ื™ืช ื”ื“ืจื•ืฉื” ืœืฆื•ืจืš ืฉื™ืคื•ืจ ืžืฆื‘ื™ ืจื•ื— ื“ื›ืื•ื ื™ื™ื. 

SAMe ื•-DHEA - ืฉื ื™ ืชื•ืกืคื™ื ืขื ื™ืขื™ืœื•ืช ืžื•ื›ื—ืช ืœืฉื™ืคื•ืจ ืžืฆื‘ื™ ื“ื™ื›ืื•ืŸ 

ื“ื•ื’ืžืื•ืช ืœื˜ื™ืคื•ืœื™ื ื˜ื‘ืขื™ื™ื, ื‘ืขืœื™ ืชื•ืงืฃ ืืžืคื™ืจื™, ื‘ืžืฆื‘ ืจื•ื— ื“ื™ื›ืื•ื ื™ื™ื ื›ื•ืœืœื™ื ืืช ืกื ื˜ ื’'ื•ืŸ ื•ื•ืจื˜ (ืคืจืข ืžื—ื•ืจืจ), ืื“ื ื•ื–ื™ืœ ืžืชื™ื•ื ื™ืŸ (SAMe), ื—ื•ืžืฆืช ื”ืืžื™ื ื• 5-ื”ื™ื“ืจื•ืงืกื™ืคื˜ืคื˜ื•ืคืŸ (5-HTP),ื™l-ืžืชื™ืœืคื•ืœื˜ื™ื˜ืžื™ืŸ - ืฆื•ืจื” ืฉืœ  ื•ื™ื˜ืžื™ืŸ B ื—ื•ืžืฆื” ืคื•ืœื™ืช, ื—ื•ืžืฆืช ื”ืฉื•ืžืŸ ื”ื—ื™ื•ื ื™ืช -ื—ื•ืžืฆื” ืื™ืงื•ืกืืคื ื˜ืื ื•ืื™ืช (EPA), ื•ื‘ืžื™ื“ื” ืคื—ื•ืชื”, ื—ื•ืžืฆืช ื”ืืžื™ื ื• ืืฆื˜ื™ืœ-ืœ-ืงืจื ื™ื˜ื™ืŸ ื•ื”ืคืจื•-ื”ื•ืจืžื•ืŸ ื“ึถื”ึดื™ื“ึฐืจื•ึน-ืึถืคึดึผื™ืึทื ึฐื“ืจื•ึนืกึฐื˜ึถืจื•ึนืŸ (Dehydroepiandrosteroneโ€ ื•ื‘ืงื™ืฆื•ืจ DHEA). ืžื—ืงืจื™ื ื›ืคื•ืœื™ ืกืžื™ื•ืช, ืžื‘ื•ืงืจื™ ืคืœืฆื‘ื•, ืžืจืื™ื ื›ื™ ื”ื™ืขื™ืœื•ืช ื ื•ื’ื“ืช ื”ื“ื™ื›ืื•ืŸ ืฉืœ SAMe ื”ื™ื ืฉื•ื•ืช ืขืจืš ืื• ืขื“ื™ืคื” ื‘ื”ืฉื•ื•ืื” ืœื ื•ื’ื“ื™ ื“ื™ื›ืื•ืŸ ื˜ืจื™ืฆื™ืงืœื™ื™ื. 

ืžื˜ื”-ืื ืœื™ื–ื•ืช ืฉืœ ืžื—ืงืจื™ื ืžื‘ื•ืงืจื™ ืคืœืฆื‘ื• ืžืจืื™ื ื›ื™ ืกืคืง ื”ืžืชื™ืœ  S-ืื“ื ื•ื–ื™ืœ-ืžืชื™ื•ื ื™ืŸ (SAMe) ื™ืขื™ืœ ื›ืžื• ืชืจื•ืคื•ืช ืžืจืฉื ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ ื›ืืฉืจ ื ื•ื˜ืœื™ื ืื•ืชื• ืœื‘ื“, ื•ืžืฉืคืจ ืืช ื”ืชื’ื•ื‘ื” ื”ื›ืœืœื™ืช ื•ืขืฉื•ื™ ืืฃ ืœื”ืื™ืฅ ืื•ืชื”, ื›ืืฉืจ ื ื•ื˜ืœื™ื ืื•ืชื• ื‘ืฉื™ืœื•ื‘ ืขื ืชืจื•ืคื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ. ืžื—ืงืจ ื—ืฉื•ื‘ ืฉืคื•ืจืกื ื‘ื›ืชื‘ ื”ืขืช ื”ืืžืจื™ืงืื™ ืœืคืกื™ื›ื™ืื˜ืจื™ื” (American Journal of Psychiatry) ื“ื™ื•ื•ื— ื›ื™ ืœ-SAMe ืขืฉื•ื™ื™ื ืœื”ื™ื•ืช ื’ื ื™ืชืจื•ื ื•ืช ืžืฉืžืขื•ืชื™ื™ื ื‘ืฉื™ืคื•ืจ ืžืฆื‘ ื”ืจื•ื— ืฉืœ ืื ืฉื™ื ืฉืื™ื ื ืžื’ื™ื‘ื™ื ืœื˜ื™ืคื•ืœ ื‘ื ื•ื’ื“ื™ ื“ื™ื›ืื•ืŸ. ืฉื™ืœื•ื‘ SAMe ืขื ืชืจื•ืคื” ื ื’ื“ ื“ื™ื›ืื•ืŸ ื”ื™ื ื“ืจืš ืื™ื ื˜ื’ืจื˜ื™ื‘ื™ืช ื‘ื˜ื•ื—ื” ืœื˜ื™ืคื•ืœ ื‘ืžืฆื‘ ืจื•ื— ื“ื™ื›ืื•ื ื™ ืฉืขืฉื•ื™ื”, ื‘ืžืงืจื™ื ืžืกื•ื™ืžื™ื, ืœืืคืฉืจ ืœืžื˜ื•ืคืœื™ื ืœื”ืคื—ื™ืช ื‘ื›-30% ืืช ื”ืžื™ื ื•ืŸ ืฉืœ ืชืจื•ืคื•ืช ืžืจืฉื ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ. ื‘ื ื•ืกืฃ ืœืฉื™ืคื•ืจ ื”ื™ืขื™ืœื•ืช ืฉืœ ืชืจื•ืคื•ืช ื ื•ื’ื“ื•ืช ื“ื™ื›ืื•ืŸ, ืงื™ื™ืžื•ืช ืขื“ื•ื™ื•ืช ืœื›ืš ืฉืฉื™ืžื•ืฉ ื ื•ืกืฃ ื‘-SAMe ืขืฉื•ื™ ืœื”ืคื—ื™ืช ืชื•ืคืขื•ืช ืœื•ื•ืื™ ืžื™ื ื™ื•ืช ื”ื ื’ืจืžื•ืช ืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ืขืœ ื™ื“ื™ SSRIs ื•ื ื•ื’ื“ื™ ื“ื™ื›ืื•ืŸ ืื—ืจื™ื. ืœืกื™ื•ื, ื ื˜ื™ืœืช 400 ืž"ื’ ืฉืœ SAMe ืคืขืžื™ื™ื ื‘ื™ื•ื ื‘ื™ื—ื“ ืขื ืชืจื•ืคื” ื ื’ื“ ื“ื™ื›ืื•ืŸ ืขืฉื•ื™ื” ืœืฉืคืจ ืืช ื”ื–ื™ื›ืจื•ืŸ ื•ื‘ืขื™ื•ืช ืงื•ื’ื ื™ื˜ื™ื‘ื™ื•ืช ืื—ืจื•ืช ืฉืœืขื™ืชื™ื ืงืจื•ื‘ื•ืช ื ืœื•ื•ืช ืœืžืฆื‘ื™ ืจื•ื— ื“ื™ื›ืื•ื ื™ื™ื. 

ื‘ื“ื•ืžื” ืœ-SAMe, ื ื˜ื™ืœืช ื”ื ื•ื™ืจื•ืกื˜ืจื•ืื™ื“ ื“ึถื”ึดื™ื“ึฐืจื•ึน-ืึถืคึดึผื™ืึทื ึฐื“ืจื•ึนืกึฐื˜ึถืจื•ึนืŸ (Dehydroepiandrosteroneโ€ ื•ื‘ืงื™ืฆื•ืจ DHEA)  ืœื‘ื“ (ืœืœื ืชืจื•ืคื•ืช ืื—ืจื•ืช) ืขืฉื•ื™ื” ืœื”ืคื—ื™ืช ืืช ื—ื•ืžืจืช ืžืฆื‘ ื”ืจื•ื— ื”ื“ื™ื›ืื•ื ื™, ื•ื ื™ืชืŸ ืœื”ืฉืชืžืฉ ื‘ื• ื‘ื‘ื˜ื—ื” ื‘ืฉื™ืœื•ื‘ ืขื ื ื•ื’ื“ื™ ื“ื™ื›ืื•ืŸ ื•ื”ื•ื ืืฃ ืžื’ื‘ื™ืจ ืืช ื™ืขื™ืœื•ืชื. ืจืžื•ืช ื”-DHEA ื‘ื’ื•ืฃ ื•ื‘ืžื•ื— ื™ื•ืจื“ื•ืช ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ื›ื›ืœ ืฉืžื–ื“ืงื ื™ื, ืžื” ืฉืขืฉื•ื™ ืœืขื–ื•ืจ ืœื”ืกื‘ื™ืจ ืžืงืจื™ื ืžืกื•ื™ืžื™ื ืฉืœ ื“ื™ื›ืื•ืŸ ืžืื•ื—ืจ. ืื ืฉื™ื ืจื‘ื™ื ื”ืžื’ื™ื‘ื™ื ืœ-DHEA ืžื“ื•ื•ื—ื™ื ื’ื ืขืœ ืฉื™ืคื•ืจ ื‘ืชืคืงื•ื“ ื”ืžื™ื ื™. 

ื”ืคื ื™ื•ืช:

  1. Dome P, Tombor L, Lazary J, Gonda X, Rihmer Z. (2019) Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review. Brain Res Bull. 146:51-78. 
  2. LaChance LR, Ramsey D. (2018) Antidepressant foods: An evidence-based nutrient profiling system for depression. World J Psychiatry. 20;8(3):97-104. 
  3. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia. JAMA. 1996 Jul 24-31;276(4):313-8.
  4. Field T, Diego M, Cullen C, Hernandez-Reif M, et al (2002) .Fibromyalgia pain and substance P decrease and sleep improves after massage therapy. J Clin Rheumatol. 8(2):72-6.
  5. Morin CM, Colecchi C, Stone J, Sood R, Brink D.(1999) Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 17;281(11):991-9.
  6. Murtagh DR, Greenwood KM. (1995)  Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995 Feb;63(1):79-89.
  7. Morin CM, Culbert JP, Schwartz SM.(1994) Nonpharmacological interventions for insomnia : A meta-analysis of treatment efficacy. Am J Psychiatry. 151(8):1172-80.
  8. Garfinkel D, Zisapel N, Wainstein J, Laudon M (1999) Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med. 8;159(20):2456-60.
  9. Wright A, Diebold J, Otal J, Stoneman C, Wong J, et al (2015) The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis. Drugs Aging.;32(12):1009-18. 
  10. Schuch F, Vancampfort D, Firth J, Rosenbaum S, Ward P, et al (2017)  Physical activity and sedentary behavior in people with major depressive disorder: A systematic review and meta-analysis. J Affect Disord. 1;210:139-150. 
  11. Gourgouvelis J, Yielder P, Murphy B. (2017) Exercise Promotes Neuroplasticity in Both Healthy and Depressed Brains: An fMRI Pilot Study. Neural Plast. 
  12. Kvam S, Kleppe CL, Nordhus IH, Hovland A.(2016) Exercise as a treatment for depression: A meta-analysis. J Affect Disord. 15;202:67-86. 
  13. Mura G, Moro MF, Patten SB, Carta MG. (2014) Exercise as an add-on strategy for the treatment of major depressive disorder: a systematic review. CNS Spectr.;19(6):496-508. 
  14. Oertel-Knรถchel V, Mehler P, Thiel C, Steinbrecher K, Malchow B, et al (2014).Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients.
  15. Eur Arch Psychiatry Clin Neurosci. 264(7):589-604. 
  16. Rethorst CD, Sunderajan P, Greer TL, Grannemann BD, Nakonezny PA, et al (2012).Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
  17. Psychol Med.;43(4):699-709.